WILLIAM M. YARBROUGH
CURRICULUM VITAE
WORK ADDRESS: Medical University of South Carolina
Department of Cardiothoracic Surgery
Ashley River Tower
** ********* ***** - ***** ****
Charleston, South Carolina 29425
Phone: 843-***-****
E-MAIL ADDRESS abpl83@r.postjobfree.com
CITIZENSHIP: United States
EDUCATIONAL BACKGROUND:
College: Duke University, B.S.
Durham, North Carolina. 1995
Post-Graduate: University of South Carolina
School of Medicine, M.D.
Columbia, South Carolina. 1999
EMPLOYMENT EXPERIENCE:
Intern, General Surgery Medical University of South Carolina
Charleston, South Carolina
July 1, 1999 June 30, 2000
Junior Resident, General Surgery Medical University of South Carolina
Charleston, South Carolina
July 1, 2000 June 30, 2001
National Institute of Health Medical University of South Carolina
Institutional Postdoctoral Research Fellowship Charleston, South Carolina
(NIH-HL 07260) July 1, 2001 June 30, 2003
Senior Resident, General Surgery Medical University of South Carolina
Charleston, South Carolina
July 1, 2003 June 30, 2005
Administrative Chief Resident, General Surgery Medical University of South Carolina
Charleston, South Carolina
July 1, 2005 June 30, 2006
Resident, Cardiothoracic Surgery Stanford University Medical Center
Stanford, California
July 1, 2006 June 30, 2009
Assistant Professor, Cardiothoracic Surgery Medical University of South Carolina
Charleston, South Carolina
July, 2009 Present
MEDICAL LICENSE: South Carolina #23969
(Expires 6/30/2011)
California #A93635
(Expires 8/31/2011)
BOARD CERTIFICATION: American Board of Surgery
#51711 (Expires 7/1/2017)
American Board of Thoracic Surgery
#7723 (Expires 12/31/2020)
AWARDS/HONORS:
1) Surgery Medal
University of South Carolina School of Medicine
2) Surgical Intern of the Year
Medical University of South Carolina Department of Surgery
Charleston, South Carolina. 2000
3) Dabney R. Yarbrough Resident Research Award
Medical University of South Carolina
Department of Surgery
Charleston, South Carolina. 2003
4) Third Edward D. Churchill Research Scholarship, 2009-2011
American Association for Thoracic Surgery
MANUSCRIPT PUBLICATIONS:
1. Yarbrough WM, Spinale FG. Large animal models of congestive heart failure: a
critical step in translating basic observations into clinical applications. J Nucl Cardiol.
2003 Jan-Feb;10(1):77-86. Review.
2. Yarbrough WM, Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Escobar GP, Joffs C,
Lucas DG, Crawford FA Jr, Spinale FG. Matrix metalloproteinase inhibition modifies
left ventricular remodeling after myocardial infarction in pigs. J Thorac Cardiovasc
Surg 2003 Mar;125(3):602-10.
3. Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS,
Escobar GP, Lucas DG, Yarbrough WM, Zile MR, Spinale FG. Myocardial infarct
expansion and matrix metalloproteinase inhibition. Circulation. 2003 Feb 4;107(4):618-
25.
4. Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW,
Dowdy KB, McLean JE, Lowry AS, O'Neill TP, Spinale FG. Selective targeting and
timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Circulation. 2003 Oct 7;108(14):1753-9
5. Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW,
Dowdy KB, McLean JE, Stroud RE, Spinale FG. Direct inhibition of the
sodium/hydrogen exchanger after prolonged regional ischemia improves contractility
on reperfusion independent of myocardial viability. J Thorac Cardiovasc Surg. 2003
Nov;126(5):1489-97.
6. Yarbrough WM, Mukherjee R, Escobar GP, Hendrick JW, Sample JA, Dowdy KB,
McLean JE, Mingoia JT, Crawford FA, Spinale FG. Modulation of calcium transport
improves myocardial contractility and enzyme profiles after prolonged ischemia-
reperfusion. Ann Thorac Surg. 2003 Dec;76(6):2054-61.
7. Yarbrough WM, Mukherjee R, Escobar GP, Sample JA, McLean JE, Dowdy KB,
Hendrick JW, Gibson WC, Hardin AE, Mingoia JT, White PC, Stiko A, Armstrong RC,
Crawford FA, Spinale FG. Pharmacologic inhibition of intracellular caspases after
myocardial infarction attenuates left ventricular remodeling: a potentially novel
pathway. J Thorac Cardiovasc Surg. 2003 Dec;126(6):1892-9.
8. Mukherjee R, Yarbrough WM, Reese ES, Leiser JS, Sample JA, Mingoia JT, Hardin
AE, Stroud RE, McLean JE, Hendrick JW, Spinale FG. Myocyte contractility with
caspase inhibition and simulated hyperkalemic cardioplegic arrest. Ann Thorac Surg.
2004 May;77(5):1684-9.
9. Deschamps AM, Yarbrough WM, Squires CE, Allen RA, Dowdy KB, McLean JE,
Mingoia JT, Sample JA, Mukherjee R, Spinale FG. Trafficking of the membrane type-1
matrix metalloproteinase (MT1-MMP) in ischemia and reperfusion: Relation to
interstitial MT1-MMP activity. Circulation. 2005 Mar 8;111(9):1166-74
10. Yarbrough WM, Mukherjee R, Squires CE, Reese ES, Leiser JS, Stroud RE, Sample
JA, Hendrick JW, Mingoia JT, McLean JE, Hardin AE, Dowdy KB, Spinale FG.
Caspase inhibition attenuates contractile dysfunction following cardioplegic arrest and
rewarming in the setting of left ventricular failure. J Cardiovasc Pharmacol. 2004
Dec;44(6):645-50.
11. Blom AS, Mukherjee R, Pilla JJ, Lowry AS, Yarbrough WM, Mingoia JT, Hendrick JW,
Stroud RE, McLean JE, Affuso J, Gorman RC, Gorman JH 3rd, Acker MA, Spinale FG.
Cardiac support device modifies left ventricular geometry and myocardial structure
after myocardial infarction. Circulation. 2005 Aug 30;112(9):1274-83.
12. Deschamps AM, Apple KA, Leonardi AH, McLean JE, Yarbrough WM, Stroud RE,
Clark LL, Sample JA, Spinale FG. Myocardial interstitial matrix metalloproteinase
activity is altered by mechanical changes in LV load: interaction with the angiotensin
type 1 receptor. Circ Res. 2005 May 27;96(10):1110-8.
13. Apple KA, Yarbrough WM, Mukherjee R, Deschamps AM, Escobar PG, Mingoia JT,
Sample JA, Hendricks JW, Dowdy KB, McLean JE, Stroud RE, O Neill TP, Spinale
FG. Selective targeting of matrix metalloproteinase inhibition in post-infarction
myocardial remodeling. J Cardiovasc Pharmacol. 2006 Feb;47(2):228-35.
14. Flack EC, Lindsey ML, Squires CE, Kaplan BS, Stroud RE, Clark LL, Escobar PG,
Yarbrough WM, Spinale FG. Alterations in cultured myocardial fibroblast function
following the development of left ventricular failure. J Mol Cell Cardiol. 2006
Apr;40(4):474-83.
15. Ruddy JM, Yarbrough W, Brothers T, Robison J, Elliott B. Abdominal aortic
aneurysm and significant coronary artery disease: strategies and options. South Med
J. 2008 Nov;101(11):1113-116
16. Yarbrough WM, Bates MJ, Deuse T, Tang DG, Robbins RC, Reitz BA, Mallidi HR.
Alternative technique for salvage of donor lungs with insufficient atrial cuffs. Ann
Thorac Surg. 2009 Oct;88(4):1374-6.
17. Yarbrough WM, Mukherjee R, Stroud RE, Meyer EC, Escobar GP, Sample JA,
Hendrick JW, Mingoia JT, Spinale FG. Caspase inhibition modulates left ventricular
remodeling following myocardial infarction through cellular and extracellular
mechanisms. J Cardiovasc Pharmacol. 2010 Apr;55(4):408-16.
BOOK CHAPTERS:
1. Payne KJ, Yarbrough WM, Ikonomidis JS, Reeves ST. Transesophageal
echocardiography of the thoracic aorta. From, A practical approach to
transesophageal echocardiography. Perrino AC and Reeves ST. Lippincott Williams
and Wilkins. Copyright 2003
PRESENTATIONS AT PEER REVIEWED REGIONAL / NATIONAL MEETINGS:
1. Yarbrough WM, Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Escobar GP, Joffs C,
Lucas DG, Crawford FA, Spinale FG. Targeting matrix metalloproteinases alters the
course of post-myocardial infarction remodeling: identification of novel therapeutic
strategies. C. Walton Lillehei Resident Forum Session. 82nd Annual Meeting of The
American Association For Thoracic Surgery, Washington, D.C., May 2002
2. Yarbrough WM, Mukherjee R, Brinsa TA, Thornton JL, Sample JA, Dowdy, KB,
O Neill TP, Escobar GP, Spinale FG. Selective matrix metalloproteinase inhibition
influences regional myocardial geometry and reduces LV dilation following myocardial
infarction. 75th Scientific Session of the American Heart Association, Chicago,
November 2002
3. Deschamps AM, Yarbrough WM, Sample JA, McLean JE, Mingoia JT, Dowdy KB,
Mukherjee R, Hendrick JW, Stroud RE, Spinale FG. Persistent and selective activation
of matrix metalloproteinases within the myocardial interstitial space following ischemia-
reperfusion. 75th Scientific Session of the American Heart Association, Chicago,
November 2002
4. Invited discussant at the 2003 Annual Scientific Meeting of the Southeastern Surgical
Congress, Residents Forum, discussing manuscript entitled The Cost of Trauma,
presented by Dr. Stephen Lanzarotti, Savannah, Georgia, February 2003
5. Yarbrough WM, Mukherjee R, Escobar GP, Sample JA, McLean JE, Dowdy KB,
Hendrick JW, Gibson WC, Hardin AE, Mingoia JT, White PC, Stiko A, Armstrong RC,
Crawford FA, Spinale FG. Pharmacologic inhibition of intracellular caspases following
ischemia-reperfusion attenuates left ventricular remodeling: a potentially novel
pathway. Cardiac Surgery Forum Session. 83rd Annual Meeting of The American
Association For Thoracic Surgery, Boston, May 2003
6. Yarbrough WM, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB,
Stroud RE, Crawford FA, Spinale FG. Na+/H+ exchanger inhibition following
prolonged ischemia improves contractility upon reperfusion independent of myocardial
viability. Surgical Forum. 89th Annual Clinical Congress Meeting of the American
College of Surgeons, Chicago, October 2003
7. Mukherjee R, Reese ES, Multani MM, Yarbrough WM, Dowdy KB, Mingoia JT,
Hendrick JW, Stroud RE, Hardin AE, McLean JE, Leiser JS, Blom AS, Pilla JJ, Affuso
J, Acker MA, Spinale FG. Passive restraint following myocardial infarction modifies left
ventricular and myocyte remodeling and improves isolated myocyte contractile
response. Heart Failure Society of America. Las Vegas, September 2003
8. Yarbrough WM, Reese ES, Leiser JS, Multani MM, Hardin AE, McLean JE, Sample
JA, Stroud RE, Hendrick JW, Mukherjee R, Spinale FG. Effects of caspase inhibition
on left ventricular myocyte contractile function following cardioplegic arrest and
rewarming in a model of pacing induced heart failure. Heart Failure Society of
America. Las Vegas, September 2003
9. Yarbrough WM, Mukherjee R, Escobar GP, Sample JA, McLean JE, Hendrick JW,
White PC, Stiko A, Armstrong RC, Spinale FG. Effects of Caspase Inhibition on Left
Ventricular Dilation Following Myocardial Infarction. Heart Failure Society of America.
Las Vegas, September 2003
10. Chapman RE, Lindsey ML, Squires C, Yarbrough WM, Leiser JS, Gardner KC, Reese
ES, Butler JE, Spinale FG. Alterations in myocardial fibroblast adhesion in left
ventricular remodeling and failure. Heart Failure Society of America. Las Vegas,
September 2003
11. Yarbrough WM, Sample JA, Mukherjee R, McLean JE, Hendrick JW, Escobar GP,
Dowdy KB, Mingoia JT, O Neill TP, Spinale FG. Selective inhibition of matrix
metalloproteinase species favorably modifies left ventricular remodeling post
myocardial infarction. Heart Failure Society of America. Las Vegas, September 2003
12. Lowry AS, Yarbrough WM, Mukherjee R, Allen RA, Deschamps AM, Escobar GP,
Sample JA, Hendrick JW, Spinale FG. Selective targeting of matrix metalloproteinase
(MMP) inhibition reduces myocardial MMP activity and LV remodeling post myocardial
infarction. Heart Failure Society of America. Las Vegas, September 2003
13. Deschamps AM, Yarbrough WM, Allen RA, Dowdy KB, McLean JE, Mingoia JT,
Sample JA, Mukherjee R, Spinale FG. The discordance between localized induction of
membrane type-MMPs and tissue inhibitors with ischemia and reperfusion: a potential
therapeutic target. Heart Failure Society of America. Las Vegas, September 2003
14. Deschamps AM, Yarbrough WM, Allen RA, Squires CE, McLean JE, Mingoia JT,
Sample JA, Mukherjee R, Spinale FG. Membrane trafficking of the membrane type-1
matrix metalloproteinase in ischemia and reperfusion: Relation to interstitial activity.
77th Scientific Session of the American Heart Association, New Orleans, November
2004
ino AC and Reeves ST. Lippincott Williams
and Wilkins. Copyright 2003